Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Actuate Therapeutics closed an underwritten public offering of 30,985,900 shares of common stock and warrants to purchase 15,492,950 shares, raising gross proceeds of approximately $11.0 million. The offering was priced at $0.71 per set of two shares and one warrant, implying a per-share price of $0.355. The company intends to use the net proceeds for working capital and general corporate purposes.
The Bank of New York Mellon Corporation entered into an underwriting agreement for the public offering of 1,250,000 depositary shares, each representing a 1/100th interest in a share of Series O Noncumulative Perpetual Preferred Stock. The company filed a Certificate of Designations to establish the rights of the new Series O Preferred Stock, which includes certain restrictions on common stock dividends if preferred dividends are not paid.
Milestone Pharmaceuticals received a deficiency notice from Nasdaq on October 23, 2026, because its common shares failed to maintain a minimum bid price of $1.00 for 30 consecutive business days. The company has until April 21, 2027, to regain compliance by having its shares close at $1.00 or higher for at least 10 consecutive business days.
BRC Group Holdings M&A Deal with B. Riley Securities Holdings, Inc.
BRC Group Holdings completed a short-form merger of its indirect subsidiary, B. Riley Securities Holdings, Inc. (BRSH), after acquiring over 90% of BRSH's outstanding common stock. Remaining BRSH shareholders will receive $8.88 per share in cash, and outstanding restricted stock awards were converted into BRC common stock awards.
Santander Holdings USA M&A Deal with Webster Financial Corporation
Santander Holdings USA, Inc. (SHUSA) filed an amendment to include financial statements and pro forma information following Banco Santander's completed acquisition of Webster Financial Corporation on August 20, 2026. Immediately following the merger, Banco Santander contributed the assets and liabilities of Webster to its SHUSA subsidiary.
Geron Corporation is discontinuing its Phase 3 IMpactMF clinical trial of imetelstat in relapsed/refractory myelofibrosis based on a recommendation from an independent Data Monitoring Committee. The committee advised that the trial was unlikely to meet its primary endpoint of overall survival, although no new safety signals were observed.
Mistras Group Signs $866M M&A Deal with H.I.G. Capital
Mistras Group announced the expiration of the 40-day 'go-shop' period under its merger agreement with H.I.G. Capital, with no alternative acquisition proposals received. The company is being acquired in an all-cash transaction valued at approximately $866 million, including debt, and is now subject to 'no-shop' restrictions. The deal is expected to close in late 2026 or early 2027, pending stockholder and regulatory approvals.
SPACCircle Acquisition Corp. consummated its initial public offering (IPO) of 10,000,000 units at a price of $10.00 per unit, generating gross proceeds of $100 million. The company granted underwriters a 45-day over-allotment option for an additional 1.5 million units and listed its securities on the Nasdaq Global Market under the symbol SCQCU.
Eureka Acquisition Corp received a notification from Nasdaq granting the company an extension until January 31, 2027, to regain compliance with the Public Float Rule (Nasdaq Listing Rule 5450(a)(4)). The extension follows the company's submission of a compliance plan on October 12, 2026, after initially receiving a deficiency notice in August.
OGE Energy Corp. has established an at-the-market (ATM) equity offering program to sell up to $750 million of its common stock from time to time. The program includes a forward sale component involving multiple financial institutions acting as forward purchasers and agents. Proceeds from the offering are intended to provide the company with flexible access to capital based on market conditions and funding needs.
The AES Corporation announced that the European Commission has closed its preliminary review of the company's pending merger with Horizon Parent, L.P. under the EU Foreign Subsidies Regulation. This regulatory clearance is a key condition for the closing of the transaction, which will result in AES being taken private by investment vehicles affiliated with Global Infrastructure Partners and EQT Infrastructure.
Cycurion, Inc. filed an amendment to report the completion of its acquisition of the Video Solutions Business from Kustom Entertainment, Inc. (formerly Digital Ally, Inc.). The filing provides the required audited and pro forma financial statements for the acquired business following the closing on August 3, 2026.
CTO Realty Growth, Inc. entered into an equity distribution agreement to add BofA Securities as an additional sales agent, forward seller, and forward purchaser for its existing at-the-market (ATM) common stock offering program. The program allows for the issuance and sale of common stock with an aggregate offering price of up to $250 million. The company also amended existing agreements with its other sales agents to account for BofA's participation in the offering.
GridAI Technologies Corp. entered into a securities purchase agreement to raise approximately $2.15 million through a private placement of pre-funded warrants and common stock purchase warrants. The combined purchase price for one pre-funded warrant and one common warrant is $4.65, with proceeds intended for general corporate purposes, potential acquisitions, or debt repayment.
Cycurion, Inc. filed an amendment to its original 8-K to provide required financial statements and pro forma information following its acquisition of Secuvant, LLC. The transaction, which closed on June 3, 2026, resulted in Secuvant becoming a wholly owned subsidiary of Cycurion. The filing includes audited financial statements for Secuvant and supplemental management discussion of its financial condition.
Landmark Bancorp, Inc. filed historical financial statements for Secuvant, LLC, indicating a status update or completion related to a previously announced acquisition. The filing includes audited financial statements for 2024 and 2025, as well as unaudited results for the first half of 2026, which are required for material acquisitions under SEC rules.
ClimateRock and GreenRock Corp amended their definitive merger agreement to update the structure of the pending business combination. Key changes include removing the acquisition of TEP Renewables Limited as a closing condition, eliminating the earnout escrow, and extending the deal's outside closing date to March 31, 2027.
Silver Point Private Credit Fund Capital Raise of $24.4M
Silver Point Private Credit Fund issued and sold 903,149 unregistered common shares for aggregate proceeds of approximately $24.4 million. The shares were sold at a price of $27.02 per share to investors under existing subscription agreements.
Gossamer Bio stockholders approved the potential issuance of common stock exceeding 20% of outstanding shares in connection with a Securities Purchase Agreement dated August 20, 2026. The approval covers shares issuable upon the exercise of Pre-Funded Warrants, FDA Approval Warrants, and the conversion of Series A-1, A-2, and A-3 Preferred Stock, satisfying Nasdaq Listing Rules 5635(c) and 5635(d).
Enerpac Tool Group Signs $452M M&A Deal with Specialized Fabrication Equipment Group LLC
Enerpac Tool Group completed its acquisition of Specialized Fabrication Equipment Group LLC (SFE Group) for approximately $452 million in cash. SFE Group is a global provider of specialized fabrication, welding, and portable machining tools with a portfolio of 12 brands. The deal expands Enerpac's addressable market and is expected to be accretive to fiscal 2027 adjusted EPS.
Value
$452M
Counterparty
Specialized Fabrication Equipment Group LLC
“SFE Group is an exceptional business with premium brands, strong margins, complementary products, and a proven track record of growth. The combination expands our addressable market and strengthens our capabilities in several attractive industrial applications, to create value for our customers, employees, and shareholders.”
Paul Sternlieb, President and Chief Executive Officer of Enerpac Tool Group
“Enerpac’s global reach, technical capabilities, and operational resources provide a strong platform for our continued growth. Together, we are well positioned to deliver even greater value to our customers and partners while continuing to invest in our people, products, and innovation.”
MIRA Pharmaceuticals announced positive proof-of-concept results from an exploratory pilot study of its oral drug candidate SKNY-1 in a mouse model of obesity. The study showed significant weight and fat reduction without significant lean-mass loss or rapid weight regain compared to semaglutide, suggesting a differentiated metabolic mechanism beyond appetite suppression.
“What makes SKNY-1 particularly exciting is that our findings point toward a potentially differentiated metabolic approach, with encouraging signals regarding body composition and weight maintenance following treatment discontinuation. We believe these characteristics could become important advantages as we continue advancing SKNY-1, positioning it as a potentially valuable asset within our pipeline and an opportunity to participate in this significant global market.”
Erez Aminov, Chief Executive Officer of MIRA Pharmaceuticals
Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings issued a status update regarding its hostile takeover bid for Aurora Cannabis, responding to a ruling by the Alberta Securities Commission. Curaleaf is advocating for its enhanced offer, which it values at approximately $5.00 per share (an 86% premium), while criticizing Aurora's board for dilutive share issuances and for excluding Curaleaf from the strategic review process.
Counterparty
Aurora Cannabis Inc.
“Aurora would like shareholders to believe the ASC's ruling changes the fundamental debate. It does not. The questions confronting Aurora shareholders remain the same today as they were yesterday: why did Aurora issue shares under an ATM for less than the original offer price after Curaleaf indicated a bid was coming, why is a now 86% premium offer being dismissed as inadequate and a discounted offer, why is Curaleaf continuing to be excluded from customary diligence when others aren't, and why is the Board asking shareholders to reject a proposal before allowing a fully informed process to play out?”
Boris Jordan, Chairman of the Board and Chief Executive Officer of Curaleaf
Amphenol delivered a record-breaking Q3 2026 with 65% revenue growth, driven by a 117% surge in IT DataCom fueled by AI demand and successful integration of ComScope, leading to raised full-year guidance.
flyExclusive, Inc. announced the final determination of the post-closing purchase price for its previously completed acquisition of assets from Jet.AI Inc. As a result, the company will issue an additional 1,544,575 shares of Class A Common Stock as additional merger consideration to former SpinCo stockholders. The payment date for these shares, which include 1,419,224 shares previously held in reserve, is expected to be October 30, 2026.
Rain Enhancement Technologies (RAIN) has been granted a continued listing extension by a Nasdaq Hearings Panel. The company must satisfy specific milestones related to its proposed business combination with Tensor Networks and meet all initial listing criteria by February 16, 2027, to avoid delisting.
Ultralife Corporation has entered into a definitive agreement to be acquired by EnerSys in an all-cash tender offer valued at approximately $320 million. Shareholders will receive $16.00 per share, representing a 166% premium to the prior day's closing price, with the company becoming a wholly owned subsidiary of EnerSys upon completion.
Value
$320M
Counterparty
EnerSys
“Combining with EnerSys is an exciting next step that will allow us to unlock value and growth opportunities for both companies, while delivering substantial and certain cash value to Ultralife shareholders.”
Michael E. Manna, President and Chief Executive Officer of Ultralife Corporation
“This acquisition is a compelling strategic fit for EnerSys and directly advances our strategy to build a broader, more differentiated defense power platform.”
Shawn O'Connell, President and Chief Executive Officer of EnerSys
Fidelity Core Real Estate Fund amended its Declaration of Trust and Dealer Manager Agreement in connection with its ongoing continuous private offering of Class I, Class S, and Class F common shares. The amendments modify the terms under which Class I shares convert into Class F shares once certain aggregate subscription thresholds are met by shareholders or financial intermediary clients.
OSR Health received a written decision from the Nasdaq Hearings Panel on October 23, 2026, denying its request for continued listing and determining to delist the company's securities. The delisting follows the company's failure to regain compliance with the $1.00 minimum bid price requirement, and its securities will continue to be quoted on the over-the-counter market under the symbols OSRH and OSRHW.
CVC-PE Global Private Equity Fund Capital Raise of $36M
CVC-PE Global Private Equity Fund, LP sold unregistered limited partnership units for aggregate consideration of approximately $36.0 million as part of its continuous private offering. The units were sold across three classes (R-S, R-I, and C) at prices based on the fund's transactional net asset value as of September 30, 2026.
One Stop Systems, Inc. entered into an Equity Distribution Agreement with Piper Sandler & Co. to establish an at-the-market (ATM) offering program. The company may sell up to $50 million of its common stock from time to time at prevailing market prices. The Sales Agent will receive a commission of 3.0% of the gross sales price of any shares sold.